Condition: NSCLC (Advanced Non-small Cell Lung Cancer) · HER2 · Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
The HEROS study is an Italian observational multicenter prospective study aimed to investigate the current diagnostic and therapeutical approach towards HER2 mutated NSCLC in clinical practice. The enrolment will start in September 2024 until September 2025. A 12-months follow-up window will be performed.
This description comes directly from the study's public registry record.
Marcello Tiseo, MD, PhD · +390521704465 · goirc-heros@goirc.org
Alessandro Leonetti, MD, PhD · info@goirc.org
Always discuss trial participation with your own doctor first.
| IRCCS "Giovanni Paolo II" | Bari, BA, Italy | Active Not Recruiting |
| Istituto Romagnolo per lo Studio dei Tumori IRST "Dino Amadori" | Meldola, FC, Italy | Not Yet Recruiting |
| Arcispedale Sant'Anna | Ferrara, FE, Italy | Not Yet Recruiting |
| Ospedale Policlinico San Martino | Genova, GE, Italy | Not Yet Recruiting |
| Ospedale Versilia | Lido di Camaiore, LU, Italy | Active Not Recruiting |
| Azienda Sanitaria Toscana Nord - Ovest | Lucca, LU, Italy | Active Not Recruiting |
| IRCCS San Gerardo dei Tintori | Monza, MB, Italy | Not Yet Recruiting |
| IRCCS Ospedale San Raffaele | Milan, MI, Italy | Not Yet Recruiting |
| ASST Grande Ospedale Metropolitano Niguarda | Milan, MI, Italy | Not Yet Recruiting |
| Istituto Clinico Humanitas IRRCS | Rozzano, MI, Italy | Not Yet Recruiting |
| Azienda Ospedaliero - Universitaria di Modena | Modena, MO, Italy | Active Not Recruiting |
| Istituto Oncologico Veneto IRCCS | Padova, PD, Italy | Recruiting |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07356544